BlackRock Investment Management’s CorMedix CRMD Stock Holding History

BlackRock Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Hold	1,263	–	–	﹤0.01%	3585
2016 Q3	$16K	Buy	1,263 +85	+7%	+$795	﹤0.01%	3417
2016 Q2	$12K	Sell	1,178 -23,614	-95%	-$360K	﹤0.01%	3553
2016 Q1	$328K	Buy	24,792 +756	+3%	+$7.34K	﹤0.01%	3052
2015 Q4	$244K	Buy	24,036 +125	+0.5%	+$1.44K	﹤0.01%	3191
2015 Q3	$238K	Buy	23,911 +1,755	+8%	+$27.1K	﹤0.01%	3214
2015 Q2	$430K	Buy	22,156 +21,412	+2,878%	+$735K	﹤0.01%	3163
2015 Q1	$37K	Sell	744 -35	-4%	-$830	﹤0.01%	3352
2014 Q4	$7K	Hold	779	–	–	﹤0.01%	3790
2014 Q3	$7K	Hold	779	–	–	﹤0.01%	3790
2014 Q2	$7K	Buy	+779	New	+$6.64K	﹤0.01%	3758

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Investment Management's CRMD Position: Q4 2016 in Review

BlackRock Investment Management held its CorMedix (CRMD) position steady in Q4 2016 at 1,263 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #3585.

BlackRock Investment Management first reported a position in CRMD in Q2 2014 and has held it in 11 quarters since. The position peaked at $430K in Q2 2015. 38 funds tracked by Wall St. Rank hold CRMD as of Q4 2016.

BlackRock Investment Management held 1,263 shares of CorMedix worth $10K as of Q4 2016.
BlackRock Investment Management left its CorMedix share count unchanged in Q4 2016.
CorMedix made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3585 holding.
BlackRock Investment Management first reported a position in CorMedix in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's CorMedix position peaked at $430K in Q2 2015.
38 funds tracked by Wall St. Rank held CorMedix as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.